These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20861812)

  • 1. Promoter hypermethylation in prostate cancer.
    Park JY
    Cancer Control; 2010 Oct; 17(4):245-55. PubMed ID: 20861812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation in promoter region as biomarkers in prostate cancer.
    Yang M; Park JY
    Methods Mol Biol; 2012; 863():67-109. PubMed ID: 22359288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation as a biomarker in prostate adenocarcinoma.
    Park JY
    Methods Mol Biol; 2015; 1238():607-25. PubMed ID: 25421683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
    Shah JN; Shao G; Hei TK; Zhao Y
    BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIC1 modulates prostate cancer progression by epigenetic modification.
    Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
    Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
    Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
    Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the caveolin-1 gene promoter in prostate cancer.
    Cui J; Rohr LR; Swanson G; Speights VO; Maxwell T; Brothman AR
    Prostate; 2001 Feb; 46(3):249-56. PubMed ID: 11170154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Collagen
    Ma JB; Bai JY; Zhang HB; Gu L; He D; Guo P
    Genet Test Mol Biomarkers; 2020 Jul; 24(7):399-408. PubMed ID: 32551898
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.
    Zhu X; Leav I; Leung YK; Wu M; Liu Q; Gao Y; McNeal JE; Ho SM
    Am J Pathol; 2004 Jun; 164(6):2003-12. PubMed ID: 15161636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.
    Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J
    Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
    Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
    Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of MEIS2 in prostate cancer recurrence.
    Nørgaard M; Haldrup C; Bjerre MT; Høyer S; Ulhøi B; Borre M; Sørensen KD
    Clin Epigenetics; 2019 Oct; 11(1):147. PubMed ID: 31640805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.
    Kristensen H; Haldrup C; Strand S; Mundbjerg K; Mortensen MM; Thorsen K; Ostenfeld MS; Wild PJ; Arsov C; Goering W; Visakorpi T; Egevad L; Lindberg J; Grönberg H; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Clin Cancer Res; 2014 Apr; 20(8):2169-81. PubMed ID: 24737792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation in prostate cancer.
    Li LC; Okino ST; Dahiya R
    Biochim Biophys Acta; 2004 Sep; 1704(2):87-102. PubMed ID: 15363862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.
    Ashour N; Angulo JC; Andrés G; Alelú R; González-Corpas A; Toledo MV; Rodríguez-Barbero JM; López JI; Sánchez-Chapado M; Ropero S
    Prostate; 2014 Sep; 74(12):1171-82. PubMed ID: 24961912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.
    Gu L; Frommel SC; Oakes CC; Simon R; Grupp K; Gerig CY; Bär D; Robinson MD; Baer C; Weiss M; Gu Z; Schapira M; Kuner R; Sültmann H; Provenzano M; ; Yaspo ML; Brors B; Korbel J; Schlomm T; Sauter G; Eils R; Plass C; Santoro R
    Nat Genet; 2015 Jan; 47(1):22-30. PubMed ID: 25485837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.